Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.61 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6048619 | 0.96 | MEN1 (0.58) | LTA4HNR5A1MEN1NPC1ALDH1A1 | |
| SCHEMBL9799612 | 0.95 | NR5A1 (0.71) | LTA4HNR5A1MEN1NPC1ALDH1A1 | |
| SCHEMBL9001511 | 0.95 | NR5A1 (0.71) | LTA4HNR5A1MEN1NPC1ALDH1A1 | |
| SCHEMBL9697418 | 0.95 | NR5A1 (0.71) | LTA4HNR5A1MEN1NPC1ALDH1A1 | |
| SCHEMBL8956159 | 0.92 | LTA4H (0.61) | LTA4HNR5A1MEN1NPC1ALDH1A1 | |
| SCHEMBL6048615 | 0.92 | NR5A1 (0.67) | LTA4HNR5A1MEN1NPC1ALDH1A1 | |
| SCHEMBL6048620 | 0.92 | NR5A1 (0.67) | LTA4HNR5A1MEN1NPC1ALDH1A1 | |
| SCHEMBL11430217 | 0.90 | NR5A1 (0.60) | LTA4HNR5A1MEN1NPC1ALDH1A1 | |
| SCHEMBL19809314 | 0.88 | CA12 (0.59) | LTA4HNR5A1CA12CA1CA2 | |
| SCHEMBL29779708 | 0.88 | CA12 (0.59) | LTA4HNR5A1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103097426-B | Epoxy compounds, solidification compound and cured article thereof | DIC CORP. (JP) | 2016-03-02 | — | — | CN | disclosed |
| EP-2557103-B1 | EPOXY COMPOUND, CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | DAINIPPON INK & CHEMICALS (JP) | 2014-11-26 | — | — | EP | disclosed |
| US-8519065-B2 | Epoxy compound, curable composition, and cured product thereof | DIC CORPORATION (JP) | 2013-08-27 | — | — | US | disclosed |
| US-20130144030-A1 | EPOXY COMPOUND, CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2013-06-06 | — | — | US | disclosed |
| EP-2557103-A1 | EPOXY COMPOUND, CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | DIC Corporation (JP) | 2013-02-13 | — | — | EP | disclosed |
| WO-2012019106-A2 | POSITIVE AND NEGATIVE MODULATORS OF NMDA RECEPTORS | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2012-02-09 | — | — | WO | disclosed |
| CN-101817777-A | Photosensitive monomer, liquid crystal panel and manufacturing method thereof | AU OPTRONICS CORP | 2010-09-01 | — | — | CN | disclosed |
| CN-101819381-A | Photosensitive monomer, liquid crystal panel and manufacturing method thereof | AU OPTRONICS CORP | 2010-09-01 | — | — | CN | disclosed |
| CN-101008783-B | Photosensitive monomer, liquid crystal panel and manufacturing method thereof | AU OPTRONICS CORP | 2010-04-14 | — | — | CN | disclosed |
| CN-101008783-A | Photosensitive monomer, liquid crystal panel and manufacturing method thereof | AU OPTRONICS CORP (CN) | 2007-08-01 | — | — | CN | disclosed |
| EP-0221677-B1 | P-AMINOPHENOLS, DERIVATIVES THEREOF AND USE FOR MANUFACTURE OF A MEDICAMENT | E.R. Squibb & Sons, Inc. (US) | 1992-09-09 | — | — | EP | disclosed |
| US-4910208-A | Skin disorders, antiinflammatory agent | E. R. SQUIBB & SONS, INC. (US) | 1990-03-20 | — | — | US | disclosed |
| US-4814454-A | ANTIALLERGENS, ANTIINFLAMMATORY | E. R. SQUIBB & SONS, INC. (US) | 1989-03-21 | — | — | US | disclosed |
| EP-0221677-A2 | p-Aminophenols, derivatives thereof and use for manufacture of a medicament | E.R. Squibb & Sons, Inc. (US) | 1987-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130144030-A1 | EPOXY COMPOUND, CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | HEATR1, EEF1A1, EPN1 | LTA4H 267/4885NR5A1 860/4885MEN1 3464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.